Showing 115 of 115on this page. Filters & sort apply to loaded results; URL updates for sharing.115 of 115 on this page
BioMarin Pharmaceutical Office Photos
BioMarin announces first person treated commercially with Roctavian for ...
BioMarin enrols first patient in phase 1/2 trial of gene therapy drug ...
UCLB licences gene therapy program for haemophilia A to BioMarin - 22 ...
BioMarin Bolsters Its Pipeline With $270 Million Inozyme Buyout ...
BioMarin Pharmaceutical Inc. - U.S. Food and Drug Administration ...
BioMarin Pharmaceutical Inc. on LinkedIn: As we celebrate 24 years of ...
Biomarin pharmaceutical inc Banque de photographies et d’images à haute ...
BioMarin – ESPE ESE 2025
BioMarin Pharmaceutical Inc. $BMRN Stake Cut by Assenagon Asset ...
BioMarin shares clinical development update - Parent Project Muscular ...
BioMarin acquires Amicus in $4.8B move for rare disease drugs.
BioMarin Hit with DOJ Subpoena on Sponsored Testing for Rare Diseases ...
Register to learn more - BioMarin Brineura HCP EN-US
BioMarin Pharmaceutical, rotated logo, white background B Stock Photo ...
BioMarin Pharmaceutical Inc. on LinkedIn: It’s all about working to get ...
Biomarin hi-res stock photography and images - Alamy
Biomarin Omega 20Cps Molli 20 pz - Redcare
BioMarin Pharmaceutical - Crunchbase Company Profile & Funding
BioMarin gets first access deal in EU for gene therapy Roctavian ...
In this photo illustration, the BioMarin Pharmaceutical logo is ...
Biomarin Projects :: Photos, videos, logos, illustrations and branding ...
BioMarin Pharmaceutical Company Profile - Office Locations, Competitors ...
Should You Buy BioMarin Pharmaceutical Before Feb. 18? | The Motley Fool
BioMarin Pharmaceutical Inc. on LinkedIn: #pantheon2023
Biomarin fact sheet_022317 | PDF
BioMarin Pharmaceutical | Global Biotechnology Company
BioMarin Pharmaceutical Inc. on LinkedIn: #hiring
BioMarin Shanbally Manufacturing brand identity by Mary Fleming Design ...
News | BioMarin
BioMarin Trial Halt Raises Another Safety Flag On AAV Gene Therapy
Biomarin Pharmaceutical Facts For Kids | AstroSafe Search
BioMarin Pharmaceutical Inc. on LinkedIn: BioMarin is excited to ...
Support for Society | BioMarin
BioMarin scales back launch for hemophilia gene therapy, pitches path ...
BioMarin passes CEO torch to Genentech’s Alexander Hardy
Working at BioMarin Pharmaceutical | Glassdoor
BioMarin Pharmaceutical Inc.’s (BMRN) Phenylketonuria Candidate Drug ...
BioMarin to acquire Amicus Therapeutics for $4.8 billion - PharmaLive
BMRN Stock Jumps 12% as Activist Elliott Targets BioMarin ...
Biomarin Pharmaceuticals Inc (BMRN) – SmartTrading
BMRN Share Price and News / Biomarin Pharmaceutical Inc. - Registered ...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is Preparing to Release PEG ...
BioMarin nabs FDA review for dwarfism drug vosoritide, forgoes AdComm ...
BioMarin Pharmaceutical Inc. Títulos — Taxas de Títulos Corporativos ...
BioMarin mantendrá Roctavian en su cartera recortando los costes en I+D ...
BMRN | BioMarin Announces Oral Presentation of 2-Year Analysis of ...
BioMarin wins FDA approval for injection to increase growth in children ...
BioMarin Pharmaceutical Inc. on LinkedIn: BioMarin has built one of the ...
FinancialContent - BioMarin Pharmaceutical (NASDAQ:BMRN) Reports ...
BioMarin (BMRN) » BioInvest
Bay Area biotech firm BioMarin to lay off 225 workers
BioMarin lays off 225 employees as it cuts spending on gene therapy ...
BioMarin Pharmaceutical upgraded to Outperform ahead of investor day ...
BioMarin PharmaceuticalVector SVG & PNG Logo - Download Free SVG & PNG ...
BioMarin expands its Cork facility to add drug product filling capability
BioMarin Narrows Roctavian Efforts to U.S., Germany, Italy as Sales ...
BioMarin Pharmaceutical Inc. on LinkedIn: The FDA has approved ...
BioMarin Pharmaceutical Inc. en LinkedIn: As we remain dedicated to the ...
BioMarin faces potential 3-month delay for Hemophilia A gene therapy ...
BioMarin Pharmaceutical 2026 Company Profile: Stock Performance ...
BioMarin gene therapy shows positive Phase III results in hemophilia A ...
Biotech Stocks: BioMarin Scores Breakout After FDA Announcement ...
BioMarin Valuation Fair, But Expectations From Hemophilia Therapy Too ...
BioMarin Pharmaceutical Inc. Executive Team | Comparably
BioMarin Pharmaceutical Inc. (BMRN) is a Prime Takeover Target ...
BioMarin to Present at the 42nd Annual J.P. Morgan Healthcare ...
BioMarin Logo - LogoDix
Biomarin adquiere Amicus, raras - Pharmabiz.NET
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding ...
BioMarin Announces Oral Presentation of Positive One-Year Results from ...
BioMarin Abandons Gene Therapy Roctavian, Cuts Revenue Guidance as ...
BioMarin Pharmaceutical Inc. on LinkedIn: Forbes Names BioMarin Among ...
Activist investor takes $1B stake in BioMarin amid CEO change ...
BioMarin Names New R&D and Business Development Leaders | Contract Pharma
BioMarin Pharmaceutical, Logo, White background Stock Photo - Alamy
BioMarin Pharmaceutical Inc. on LinkedIn: #earthday
BioMarin to buy rare disease drugmaker Inozyme for $270M | BioPharma Dive
史上最贵？BioMarin正考虑将A型血友病基因疗法定价200万至300万美元
U.S. Food and Drug Administration Approves BioMarin's ROCTAVIAN ...
bmrn-20250407
BMN-333 - Drug Targets, Indications, Patents - Synapse
BioMarin's Strategic $270 Million Acquisition of Inozyme Pharma ...
What's the secret to building a world class manufacturing organization ...
Substitution Therapy Stock Photos, Pictures & Royalty-Free Images - iStock
Updated: BioMarin’s hemophilia A gene therapy Roctavian wins FDA ...
Biotechnology News - BioMarin's New Data for Haemophilia Gene Therapy
【行业资讯】BioMarin向FDA重新提交A型血友病基因治疗药物ROCTAVIAN的上市申请 - 知乎
GEN - For Healthier GENerations - GEN
U.S. FDA clears BioMarin's Voxzogo as first approved therapy for ...
REMS Industry Consortium on LinkedIn: RIC is excited to welcome ...
BioMarine®Medical Immuno & Neuro Lipids (60 capseln = 62,4 ml ...
First Gene Therapy for Adults with Severe Hemophilia A, BioMarin's ...
Cell and Gene Therapy - BioSpace
BioMarin: Warum die Aktie jetzt Chancen bietet
Health and Pharma on LinkedIn: BioMarin's Revolutionary Gene Therapy ...
EU clears BioMarin's Roctavian gene therapy for haemophilia A
Beyond Rare Disease: Wet AMD Gene Therapy Could Reach Millions - BioSpace
